SSAT SSAT
 
 
Abstracts Only
SSAT residents Corner
Find SSAT on Facebook SSAT YouTube Channel Follow SSAT on Twitter
SSAT
 
SSAT 51st Annual Meeting Abstracts

Back to Program | 2010 Program and Abstracts Overview | 2010 Posters


The Influence of Incidental Gastrointestinal Stromal Tumors On the Treatment of Patients Undergoing Resection of Upper Gastrointestinal Malignancies
Carlos H. Chan*1, Jonathan Cools-Lartigue1, Jonathan Spicer1, Mathieu Rousseau1, Victoria Marcus2, Liane S. Feldman1, Lorenzo E. Ferri1
1Surgery, McGill University, Montreal, QC, Canada; 2Pathology, McGill University, Montreal, QC, Canada

Background: There are emerging data to suggest that asymptomatic gastrointestinal stromal tumors (GIST) of the stomach are not uncommon. We sought to determine the incidence of these tumors in patients undergoing resection for epithelial tumors of the foregut as well as the impact on surgical and adjuvant treatment. Methods: A prospectively entered database chronicling all patients undergoing resection of non-GIST malignancies of the stomach and esophagus at a single university center over a 4-year period was accessed, and pathology reports were reviewed for the presence of synchronous GISTs. Patient demographics, tumor characteristics, operative procedures, and post-operative outcomes were reviewed for patients in whom a synchronous GIST was identified. Data presented as median (range).Results: From July 2005 to November 2009, 186 patients underwent gastrectomy (N=62) or esophagectomy (N=124) for a non-GIST malignancy (142 adenocarcinoma, 29 squamous cell carcinoma, 7 other). Of these, synchronous GISTs were identified in 4.3% (8/186), pre-operatively (N=1), intra-operatively (N=4), and upon final pathology (N=3). Median age of patients was 70 years (30-84) and most were male (6/8). Operative therapy was altered in 4 of 5 patients identified pre- or intra-operatively. In these patients, a wedge resection of the stomach was performed in the eventual gastric conduit following esophagectomy. Final pathology revealed completely resected tumors of 0.65 cm (0.2 - 5 cm) with low or very low malignant potential. None of the patients received adjuvant therapy for the GIST in addition to that for the epithelial tumour. At last follow up (16 (5-25) months), 3 patients have died from disease (epithelial cancer), 2 are alive with disease (epithelial cancer), and 3 are alive without disease. In no patient has GIST recurred.Conclusion: Synchronous GIST is not an uncommon incidental finding during resection of foregut malignancies that may alter surgical treatment but is unlikely to impact long term survival.


Back to Program | 2010 Program and Abstracts Overview | 2010 Posters

 

 
Home | Contact SSAT